UC Cancer Center Debuts Outpatient CAR-T Therapy
The Cincinnati facility successfully treated a patient with genetically modified T-cells on an outpatient basis in 2026.
Updated on Oct. 26, 2026 in Cancer
In 2026, the UC Cancer Center in Cincinnati performed its first outpatient CAR-T cell therapy procedure on patient Tamara Schwarting. The treatment involves using genetically modified T-cells to target cancer, a process that now allows for home recovery rather than an extended hospital stay.
Why it matters
Transitioning CAR-T therapy to an outpatient setting aims to significantly enhance patient quality of life by removing the necessity for inpatient hospitalization. This shift allows individuals to recover in the comfort of their own homes while maintaining clinical support.
The infusion process for modified T-cells takes less than 10 minutes to complete. Patients are provided with a 24-hour nurse hotline to manage potential side effects during their recovery at home.
The players
UC Cancer Center
This Cincinnati-based medical facility specializes in advanced oncological treatments and research.
Tamara Schwarting
She is the first patient to receive the CAR-T cell therapy treatment as an outpatient at the UC Cancer Center.
The details
Medical staff at the UC Cancer Center extract a patient's own T-cells, which are then genetically modified in a laboratory before being reinfused back into the patient. To support this outpatient model, patients receive specialized training regarding potential side effects before returning home.
Timeline
May 2021: Tamara Schwarting was diagnosed with follicular lymphoma.
2026: Schwarting received the outpatient CAR-T cell therapy.
Health Landscape
The adoption of an outpatient delivery model for CAR-T cell therapy reflects a broader evolution in medical science toward decentralized care. This milestone marks a significant departure from traditional inpatient protocols for complex immunotherapy treatments.
This development allows eligible patients to recover from cell therapy in their own homes rather than a hospital room. Patients must be prepared to follow strict training protocols and utilize the provided 24-hour nurse hotline for any side effects.
The takeaway
Outpatient treatment options like this can reduce the burden of long-term hospital stays for lymphoma patients. Those considering similar therapies should consult their care team about whether an outpatient protocol is suitable for their specific clinical needs.
Further reading
Learn more about the latest advancements in oncology at the Cancer section.
Source note: This article includes information reported by WLWT5.
